| Role |
Name |
Disclosure |
Details |
| Author | Erasmo A Passaro, MD, Director, Comprehensive Epilepsy Program/Clinical Neurophysiology Lab, Bayfront Medical Center | Nothing to disclose | Details | | Coauthor | Kirk W Jobe, MD, Consulting Staff, Comprehensive Epilepsy Program, Department of Neurosurgery, Bayfront Institute of Neurosciences | Nothing to disclose | Details | | Medical Editor | Joseph F Hulihan, MD, Vice President, Medical Affairs, Ortho-McNeil Janssen Scientific Affairs, LLC | Johnson & Johnson Johnson & Johnson | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Jose E Cavazos, MD, PhD, Assistant Professor, Departments of Medicine (Neurology), Pharmacology, and Physiology, University of Texas Health Science Center at San Antonio | Glaxo-SmithKline Ortho-McNeil Neurologics UCB Pharma | Details | | CME Editor | Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital | Nothing to disclose | Details | | Chief Editor | Nicholas Y Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Kirk W Jobe, Coauthor |
The contributor discloses no conflict of interest. |
|